Symmetry Peak Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,110
Closed -$253K 136
2022
Q4
$253K Buy
+5,110
New +$209K 0.12% 88
2020
Q1
Sell
-5,000
Closed -$462K 46
2019
Q4
$462K Buy
+5,000
New +$440K 0.1% 117
2019
Q3
Sell
-3,000
Closed -$354K 133
2019
Q2
$354K Buy
+3,000
New +$302K 0.08% 132
2018
Q4
Sell
-21,000
Closed -$1.66M 83
2018
Q3
$1.66M Buy
+21,000
New +$1.37M 0.59% 35

Other funds holding EXAS

Symmetry Peak Management's EXAS Position: Q1 2023 in Review

Symmetry Peak Management sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 5,110 shares — an estimated $253K sold.

Symmetry Peak Management first reported a position in EXAS in Q3 2018 and held it in 4 quarters. The position peaked at $1.66M in Q3 2018. 584 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • Symmetry Peak Management reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • Symmetry Peak Management sold 5,110 Exact Sciences shares in Q1 2023, an estimated $253K.
  • Symmetry Peak Management first reported a position in Exact Sciences in Q3 2018 and held it in 4 quarters.
  • Symmetry Peak Management's Exact Sciences position peaked at $1.66M in Q3 2018.
  • 584 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Symmetry Peak Management's 13F filing for Q1 2023, filed 15 May 2023.